REAL-WORLD EFFECTIVENESS AND SAFETY OF RANIBIZUMAB TREATMENT IN PATIENTS WITH AND WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY: Twelve-Month Results From the LUMINOUS Study

PURPOSE: To evaluate the real-world effectiveness and safety of intravitreal ranibizumab 0.5 mg in treatment-naive patients with and without polypoidal choroidal vasculopathy (PCV). METHODS: Assessment of neovascular age-related macular degeneration patients with or without PCV after 12 months of ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Adrian, Lai, Timothy Y.Y., Wei, Wen Bin, Mori, Ryusaburo, Wakiyama, Harumi, Park, Kyu Hyung, Ngah, Fariza, Macfadden, Wayne, Dunger-Baldauf, Cornelia, Parikh, Soumil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2020
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392585/
https://www.ncbi.nlm.nih.gov/pubmed/31385918
http://dx.doi.org/10.1097/IAE.0000000000002624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392585/
https://www.ncbi.nlm.nih.gov/pubmed/31385918
http://dx.doi.org/10.1097/IAE.0000000000002624

Ejemplares similares